-W Poewe Researcher Activity Profile

Research Author Detailed Information 

W Poewe Publication Rate By Year

W Poewe has published 1 paper(s) in 1981, 2 paper(s) in 1999, 23 paper(s) in 2007, 10 paper(s) in 2008, for a total of 36 research publications in total.

W W Poewe Author Information

LAST NAME: poewe

FIRST NAME: W

INITIALS: w

AFFILIATION:

Papers

W Poewe's Publication Record

1. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Year Published: 1999
2. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Year Published: 1999
3. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Year Published: 2008
Department of Neurology, Innsbruck Medical University, Austria. gerhard.ransmayr@akh.linz.at
4. [Double bilateral carotid artery occlusion after blunt neck trauma (case report)] Year Published: 1981
5. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Year Published: 2008
Department of Neurology, Innsbruck Medical University, Austria. gerhard.ransmayr@akh.linz.at
6. Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Year Published: 2007
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
7. An open trial of levetiracetam for segmental and generalized dystonia. Year Published: 2007
Department of Neurology, Medical University Innsbruck, Austria.
8. Voxel based morphometry reveals specific gray matter changes in primary dystonia. Year Published: 2007
Department of Radiology, Innsbruck Medical University, Austria.
9. Depression in Parkinson's disease. Year Published: 2007
Dept. of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria, werner.poewe@i-med.ac.at.
10. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Year Published: 2007
Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. muratemre@superonline.com
11. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Year Published: 2007
Clinical Department of Neurology, Innsbruck Medical University, Austria.
12. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy. Year Published: 2007
13. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Year Published: 2007
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
14. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy. Year Published: 2007
Clinical Neurobiology Unit, Neurodegeneration Research Laboratory, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
15. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Year Published: 2007
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
16. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia : a retrospective analysis of a double-blind trial and an open-label extension. Year Published: 2007
Department of Neurology, Philipps University, Marburg, Germany.
17. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Year Published: 2007
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
18. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Year Published: 2007
University of South Florida, Tampa, Florida, USA.
19. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force. Year Published: 2007
20. Dysautonomia and cognitive dysfunction in Parkinson's disease. Year Published: 2008
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. werner.poewe@uibk.ac.at
21. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Year Published: 2007
Clinical Neurobiology Unit, Neurodegeneration Research Laboratory, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
22. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Year Published: 2007
Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. muratemre@superonline.com
23. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Year Published: 2007
Clinical Department of Neurology, Innsbruck Medical University, Austria.
24. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy. Year Published: 2007
25. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Year Published: 2007
Clinical Neurobiology Unit, Neurodegeneration Research Laboratory, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
26. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: Results from a prospective, randomized sham-controlled trial. Year Published: 2008
27. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Year Published: 2007
Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida 33606, USA. rhauser@hsc.usf.edu
28. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Year Published: 2007
INSERM-UPMC UMRS 610, Federation of Neurology, AP-HP, Salpêtrière Hospital; Université Paris6, Paris, France. bruno.dubois@psl.aphp.fr
29. Safety of prolonged sacral neuromodulation tined lead testing. Year Published: 2008
Department of Urology, University of Bern, Bern, Switzerland.
30. Safety of prolonged sacral neuromodulation tined lead testing. Year Published: 2008
Department of Urology, University of Bern, Bern, Switzerland.
31. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Year Published: 2007
Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida 33606, USA. rhauser@hsc.usf.edu
32. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Year Published: 2007
INSERM-UPMC UMRS 610, Federation of Neurology, AP-HP, Salpêtrière Hospital; Université Paris6, Paris, France. bruno.dubois@psl.aphp.fr
33. Dysautonomia and cognitive dysfunction in Parkinson's disease. Year Published: 2008
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria. werner.poewe@uibk.ac.at
34. Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Year Published: 2008
Department of Neurology, McKnight Brain Institute/University of Florida, Gainesville, Florida, USA.
35. Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Year Published: 2008
Department of Neurology, McKnight Brain Institute/University of Florida, Gainesville, Florida 32611, USA. fernandez@neurology.ufl.edu
36. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Year Published: 2008
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.